CRISPR Therapeutics
CRSP
#3087
Rank
S$5.19 B
Marketcap
$60.61
Share price
5.13%
Change (1 day)
-40.83%
Change (1 year)

Earnings for CRISPR Therapeutics (CRSP)

Earnings in 2024 (TTM): -S$0.49 Billion

According to CRISPR Therapeutics's latest financial reports the company's current earnings are S$35 Million. a decrease over its 2023 earnings that were of -S$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CRISPR Therapeutics from 2016 to 2024

Annual earnings

Year Earnings Change
2024 -S$0.49 Billion140.62%
2023 -S$0.21 Billion-76.83%
2022 -S$0.87 Billion-271.4%
2021 S$0.50 B-209.04%
2020 -S$0.47 Billion-617.12%
2019 S$89.59 M-140.93%
2018 -S$0.22 Billion146.86%
2017 -S$88.67 Million193.19%
2016 -S$30.25 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.2 Billion-60.60%๐Ÿ‡บ๐Ÿ‡ธ USA